Consumer Products
|
Updated on 01 Nov 2025, 12:21 pm
Reviewed By
Aditi Singh | Whalesbook News Team
▶
Bold Care, a Mumbai-based Direct-to-Consumer (D2C) startup, has announced it has crossed the ₹100 crore annual revenue run rate (ARR) mark. Since its founding in 2019, the company has seen substantial growth, increasing its revenue from ₹2.5 crore in FY21 to ₹8 crore in FY22, and now reaching this significant milestone. Co-founder and CEO Rajat Jadhav expressed confidence that Bold Care will achieve profitability within the next one to two quarters.
The brand initially focused on sensitive men's health issues such as erectile dysfunction (ED) and premature ejaculation (PE). It has since broadened its product line to encompass general sexual wellness and intimate care, and has also ventured into female intimate hygiene and wellness with its 'Bloom by Bold Care' line, which generates approximately ₹1.5 crore in monthly sales.
Bold Care positions itself as the third-largest player in India's sexual wellness market and the second-largest online condom brand. A key product contributing to its success is the premature ejaculation spray, 'Extend,' which the company states has a 98% efficacy rate.
Notable investors in Bold Care include Rainmatter, the investment arm of Zerodha founders Nithin and Nikhil Kamath, and actor Ranveer Singh, who is actively involved in the brand's strategy and campaigns. The company emphasizes its commitment to offering legitimate, clinically backed solutions to address the widespread need for accessible and private sexual health treatments in India.
Impact: This news highlights the rapid growth potential of D2C startups in niche but significant consumer segments within India. Bold Care's success in destigmatizing and providing accessible solutions for sexual wellness indicates evolving consumer attitudes and a maturing market, which could attract further investor interest in similar ventures and potentially influence the broader consumer healthcare landscape. It showcases how innovative approaches can capture market share even in established categories. Rating: 7/10
Difficult Terms: Annual Revenue Run Rate (ARR): A projection of a company's total revenue for a year, calculated based on its current financial performance and sales trends. D2C (Direct-to-Consumer): A business model where companies sell their products directly to end customers without relying on intermediaries like retailers or wholesalers. Erectile Dysfunction (ED): A medical condition characterized by a persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance. Premature Ejaculation (PE): A common sexual condition where ejaculation occurs sooner than desired, often causing distress to the individual or couple. Efficacy: The ability of a product or treatment to produce the desired or intended result under specific conditions.
Auto
Suzuki and Honda aren’t sure India is ready for small EVs. Here’s why.
Brokerage Reports
Stocks to buy: Raja Venkatraman's top picks for 4 November
Mutual Funds
Quantum Mutual Fund stages a comeback with a new CEO and revamped strategies; eyes sustainable growth
Tech
Why Pine Labs’ head believes Ebitda is a better measure of the company’s value
Banking/Finance
SEBI is forcing a nifty bank shake-up: Are PNB and BoB the new ‘must-owns’?
Industrial Goods/Services
India’s Warren Buffett just made 2 rare moves: What he’s buying (and selling)
Energy
India's green power pipeline had become clogged. A mega clean-up is on cards.
Startups/VC
a16z pauses its famed TxO Fund for underserved founders, lays off staff